Muguruma Yukari, Yahata Takashi, Miyatake Hiroko, Sato Tadayuki, Uno Tomoko, Itoh Jobu, Kato Shunichi, Ito Mamoru, Hotta Tomomitsu, Ando Kiyoshi
Division of Hematopoiesis, Research Center of Regenerative Medicine, Tokai University School of Medicine, Boseidai, Isehara, Kanagawa, 259-1193, Japan.
Blood. 2006 Mar 1;107(5):1878-87. doi: 10.1182/blood-2005-06-2211. Epub 2005 Nov 10.
Hematopoiesis is maintained by specific interactions between both hematopoietic and nonhematopoietic cells. Whereas hematopoietic stem cells (HSCs) have been extensively studied both in vitro and in vivo, little is known about the in vivo characteristics of stem cells of the nonhematopoietic component, known as mesenchymal stem cells (MSCs). Here we have visualized and characterized human MSCs in vivo following intramedullary transplantation of enhanced green fluorescent protein-marked human MSCs (eGFP-MSCs) into the bone marrow (BM) of nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. Between 4 to 10 weeks after transplantation, eGFP-MSCs that engrafted in murine BM integrated into the hematopoietic microenvironment (HME) of the host mouse. They differentiated into pericytes, myofibroblasts, BM stromal cells, osteocytes in bone, bone-lining osteoblasts, and endothelial cells, which constituted the functional components of the BM HME. The presence of human MSCs in murine BM resulted in an increase in functionally and phenotypically primitive human hematopoietic cells. Human MSC-derived cells that reconstituted the HME appeared to contribute to the maintenance of human hematopoiesis by actively interacting with primitive human hematopoietic cells.
造血作用由造血细胞和非造血细胞之间的特定相互作用维持。造血干细胞(HSCs)已在体外和体内得到广泛研究,而对于非造血成分的干细胞,即间充质干细胞(MSCs)的体内特性却知之甚少。在此,我们将增强型绿色荧光蛋白标记的人MSCs(eGFP-MSCs)经髓内移植到非肥胖糖尿病/严重联合免疫缺陷(NOD/SCID)小鼠的骨髓(BM)中,对体内的人MSCs进行了可视化和特征分析。移植后4至10周之间,植入小鼠BM的eGFP-MSCs整合到宿主小鼠的造血微环境(HME)中。它们分化为周细胞、肌成纤维细胞、BM基质细胞、骨中的骨细胞、骨内膜成骨细胞和内皮细胞,这些细胞构成了BM HME的功能成分。小鼠BM中存在人MSCs导致功能和表型上原始的人造血细胞数量增加。重建HME的人MSC衍生细胞似乎通过与原始人造血细胞积极相互作用,有助于维持人造血作用。
Cell Transplant. 2011-6-7
Cell Regen. 2024-10-11
Cell Regen. 2024-9-30
Front Cell Dev Biol. 2023-12-18
ACS Appl Mater Interfaces. 2024-1-10